Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

executive says Drugmaker Merck , known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on ...

Merck & Co., Inc. faces a complex landscape of opportunities and challenges as it navigates the evolving pharmaceutical market. While the company’s strong position in oncology and promising ...

just under half of the company's sales are generated in the United States. Merck & Co: A Financial Overview Market Capitalization: Exceeding industry standards, the company's market capitalization ...

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S. manufacturing amid President Donald Trump's tariff threats.

Shares of this pharmaceutical company have returned -14.4% over the past month versus the Zacks S&P 500 composite's +4.3% change. The Zacks Large Cap Pharmaceuticals industry, to which Merck ...

The company's strategic focus on advanced technologies may also position it favorably in a volatile... Molson Coors, Merck & Co. and Deutsche Telekom are part of the Zacks Investment Ideas article.